Category
Biologics & Advanced Therapies
Modern targeted treatments for moderate-severe IBD
Entyvio vs Humira for Crohn's Disease: Key Differences
Entyvio vs Humira for Crohn's disease: compare efficacy, infection risk, dosing and onset, including Entyvio's 10-14 week response window.
When Your UC Biologic Stops Working: Next Steps
UC biologic stopped working? Learn how therapeutic drug monitoring guides dose escalation, switching, oral options, and questions for your GI.
When Your Crohn's Biologic Stops Working: Next Steps
Crohn's biologic stopped working? Learn how drug levels and antibody tests guide dose changes or switches, and what symptom data to bring your GI.
Biologics for Crohn's Disease: Comparing Your Options in 2026
Biologics for Crohn's disease compared by drug class, remission evidence, safety and response time. Learn when to optimize, switch or use biosimilars.
JAK Inhibitors and S1P Modulators: The Newer Oral UC Treatments Explained
JAK inhibitors and S1P modulators for UC compared: learn how tofacitinib, upadacitinib, ozanimod and etrasimod differ in risks and monitoring.
Biologics for Ulcerative Colitis: Comparing Your Options in 2026
Compare biologics for ulcerative colitis across 4 drug classes, efficacy, infusions, injections, biosimilars and switching to discuss with your GI.
Before Starting Biologics for UC: TB/Hep B Screening + Vaccine Checklist
Before starting biologics for UC, use this checklist for TB tests, the hepatitis B triple panel, key vaccines, and 2-week non-live vs. 4-week live timing.
Before Starting an Anti-TNF for Crohn's: Your TB, Hepatitis B, and Vaccine Checklist
TB and hepatitis B screening before biologics: use this checklist for IGRA or TST, the 3-part HBV panel, and vaccines before anti-TNF treatment.
IL-12/23 and IL-23 Inhibitors for IBD: Stelara, Skyrizi, Omvoh, Tremfya
IL-23 inhibitors for IBD compared: learn how Stelara, Skyrizi, Omvoh and Tremfya differ by p40 vs p19 targets, dosing, trial results and safety.
Anti-Integrin Therapy for IBD: Vedolizumab vs Natalizumab
Vedolizumab vs natalizumab for IBD: compare PML risk, gut selectivity, dosing schedules, onset and trial results before discussing treatment.
Anti-TNF Biologics for IBD: How the TNF Blockers Work
Anti-TNF biologics for IBD explained: learn how TNF blockers work and compare 4 drugs, dosing schedules, approved uses, safety risks and screening.
Biosimilars & Switching
Switching to biosimilars for IBD: see evidence from 85 publications, learn what interchangeability means, and know what stays the same after a switch.